Diagnostic and prognostic contribution of targeted NGS in patients with triple‐negative myeloproliferative neoplasms
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25580
Abstract: REFERENCES 1. Taher AT, Weatherall DJ, Cappellini MD. Thalassemia. Lancet. 2018; 391(10116):155-167. 2. Cappellini MD, Porter JB, Viprakasit V, Taher AT. A paradigm shift on beta-thalassemia treatment: how will we manage this old disease with… read more here.
Keywords: diagnostic prognostic; contribution targeted; thalassemia; prognostic contribution ... See more keywords
Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening
Sign Up to like & getrecommendations! Published in 2017 at "Archives of Disease in Childhood: Fetal and Neonatal Edition"
DOI: 10.1136/archdischild-2016-311859
Abstract: Background We previously reported a 2.2% rate of infants born with sensorineural hearing loss (SNHL) due to congenital cytomegalovirus (cCMV) infection identified by universal neonatal screen for cCMV using saliva. Objective To evaluate the contribution… read more here.
Keywords: hearing loss; targeted saliva; hearing screening; contribution targeted ... See more keywords